Coral Genomics, Inc.
Rapid shallow whole genome and whole exome sequencing platform with novel sample pooling and real-time analysis for clinical variant calling
- Sector
- Medtech
- Headquarters
- San Francisco, CA
- Total capital
- $4.2M
- Federal grants
- $4.2M
- 4 awards · 2019–2021
- Rank in peer group#9 of 15
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Multiplexing methods to reduce sequencing costs$1.2M
- Federal grantHealth and Human S · Phase II · In Vitro Toxicity Testing at Massive Scale in Diverse Primary Human Cells$811K
- Federal grantHealth and Human S · Phase II · Multiplexing methods to reduce sequencing costs$2M
- Federal grantHealth and Human S · Phase I · Multiplexing methods to reduce sequencing costs.$143K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 15 peers
Line = medianMedtech · Platform
- Federal grantsBelow median
- Linked publications#2 · top 13%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 4- PendingMethods For Analyzing CellsUSPTOApplication 17122678
- PendingMethods For Analyzing CellsUSPTOApplication PCTUS2019041159
- PendingMethods For Analyzing CellsUSPTOApplication 62711444
Show all 4 patent records
- Methods For Analyzing CellsAug 26, 2021 · Application 17122678Pending
- Methods For Analyzing CellsApplication PCTUS2019041159Pending
- Methods For Analyzing CellsApplication 62711444Pending
- Generation and Screening of Population Scale Cell BanksApplication 62697972Pending
Recent research by its founders
- MULTIPLEXED CHARACTERIZATION OF AAV CELLULAR TROPISM AND PROMOTER EXPRESSION IN HORSES USING SINGLE-CELL RNA SEQUENCING20240 cites
- Correction: Anastopoulos et al. Multi-Drug Featurization and Deep Learning Improve Patient-Specific Predictions of Adverse Events. Int. J. Environ. Res. Public Health 2021, 18, 260020222 cites
- DNARecords: An extensible sparse format for petabyte scale genomics analysis20220 cites
Related companies, and why
- NeuroReform Holdings, LLCSimilar federal contract value in Medtech · null in contracts
- PARLEY NEUROTECH INCSimilar federal contract value in Medtech · null in contracts
- Okra Medical, Inc.Similar federal contract value in Medtech · null in contracts
- SPKL,LLCSimilar federal contract value in Medtech · null in contracts
- 109 Therapeutics, Inc.Similar federal contract value in Medtech · null in contracts
- LOGICINK CORPORATIONSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .